Discover our CEO’s last publication in the British Journal of Clinical Pharmacology:
In this editorial, we propose the application of the Six Sigma framework to reduce the problem of medication nonadherence, a global epidemic that creates a large impact on health care systems worldwide, due to increased mortality and the economic burden of hospitalization.
https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.13905
When bringing a new drug product to market, powerful motivating forces are involved. And while the potential for enhancing, or even extending, the lives of patients unquestionably takes primacy, there is another inescapably influential factor in the mix: profitability. For
The economic model that has underpinned the development of drug products for decades is currently under siege. Faced on one side with mounting pressure from payers to address affordability issues, pharmaceutical companies are facing ever more stringent regulatory requirements alongside